Company intelligence / Profile preview

CluePoints

Mont-Saint-Guilbert, Walloon Brabant, Belgiumcluepoints.com ↗

Ownership: Private
Development stage: Commercial

Overview

CluePoints provides AI-driven, cloud-based software solutions for risk-based quality management and data oversight in clinical trials. Its platform leverages advanced statistics and machine learning to identify anomalies, improve data integrity, support regulatory compliance, and enhance operational efficiency for pharmaceutical sponsors, CROs, and medical device companies. The technology has been used in over 1,600 studies with more than 9,500 users globally—including many of the top 20 pharma companies—and played a key role during COVID-era remote trial monitoring.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

FDA Cooperative Research and Development Agreement for site inspection analyticsTufts Center for the Study of Drug Development partnership on RBQM adoption survey

Beyond the preview

Go deeper on CluePoints.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CluePoints.

Explore the full profile